Yahoo India Web Search

Search results

      • Cardiovascular Diabetology considers manuscripts on all aspects of the diabetes/cardiovascular interrelationship and the metabolic syndrome; this includes clinical, genetic, experimental, pharmacological, epidemiological and molecular biology research.
      cardiab.biomedcentral.com/
  1. People also ask

  2. Cardiovascular Diabetology considers manuscripts on all aspects of the diabetes/cardiovascular interrelationship and the metabolic syndrome; this includes clinical, genetic, experimental, pharmacological, epidemiological and molecular biology research.

    • About

      Cardiovascular Diabetology considers manuscripts on all...

    • Articles

      First in the field to exclusively cover the link between...

    • Submission Guidelines

      Cardiovascular Diabetology is affiliated with Sackler...

    • High Visibility
    • Speed of Publication
    • Flexibility
    • Promotion and Press Coverage
    • Copyright

    Cardiovascular Diabetology's open access policy allows maximum visibility of articles published in the journal as they are available to a wide, global audience.

    Cardiovascular Diabetologyoffers a fast publication schedule whilst maintaining rigorous peer review; all articles must be submitted online, and peer review is managed fully electronically (articles are distributed in PDF form, which is automatically generated from the submitted files). Articles will be published with their final citation after acc...

    Online publication in Cardiovascular Diabetology gives you the opportunity to publish large datasets, large numbers of color illustrations and moving pictures, to display data in a form that can be read directly by other software packages so as to allow readers to manipulate the data for themselves, and to create all relevant links (for example, to...

    Articles published in Cardiovascular Diabetology are included in article alerts and regular email updates. Some may be highlighted on Cardiovascular Diabetology’s pages and on the BMC homepage. In addition, articles published in Cardiovascular Diabetology may be promoted by press releases to the general or scientific press. These activities increas...

    As an author of an article published in Cardiovascular Diabetology you retain the copyright of your article and you are free to reproduce and disseminate your work (for further details, see the BMC license agreement). For further information about the advantages of publishing in a journal from BMC, please click here.

    • The SGLT2 inhibitor Empagliflozin promotes post-stroke functional recovery in diabetic mice. Type-2 diabetes (T2D) worsens stroke recovery, amplifying post-stroke disabilities.
    • Non-insulin-based insulin resistance indexes in predicting atrial fibrillation recurrence following ablation: a retrospective study. Insulin resistance (IR) is involved in the pathophysiological processes of arrhythmias.
    • Association between different insulin resistance surrogates and all-cause mortality in patients with coronary heart disease and hypertension: NHANES longitudinal cohort study.
    • Fatty liver index is an independent risk factor for all-cause mortality and major cardiovascular events in type 1 diabetes: an 11-year observational study.
  3. First in the field to exclusively cover the link between diabetes and cardiovascular disorders, Cardiovascular Diabetology is the leading, international open access journal specifically dedicated to exploring the interrelationship between heart diseases and alterations in glucose metabolism.

  4. Cardiovascular Diabetology is a peer-reviewed open access medical journal covering the intersection of cardiology and diabetology, meaning the connection between diabetes, metabolic syndrome and cardiovascular diseases.

    • Cardiology , Diabetology
  5. Cardiovascular Diabetology is an open access, peer-reviewed, online journal that considers manuscripts on all aspects of the diabetes/cardiovascular interrelationship and the dysmetabolic syndrome; this includes genetic, experimental, clinical, pharmacological, epidemiological, molecular biology and laboratory research.

  6. Jan 24, 2024 · Cardiovascular disease (CVD) is the leading cause of death in people with diabetes. People with diabetes have up to a fourfold increased risk of stroke and are twice as likely to die after myocardial infarction than people without diabetes.